Author

Bin Xu

Tongji UniversityORCID 0000-0003-3884-6573Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Bin Xu1 paper · First Affiliated Hospital Zhejiang University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Chunfeng WangiD· 1 shared Chunwei ShiiD· 1 shared Dongqin YangiD· 1 shared Guilian YangiD· 1 shared Haibin HuangiD· 1 shared Jianzhong WangiD· 1 shared Junhong WangiD· 1 shared Mingyang ChengiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Chunfeng WangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologymBioPeer-reviewedAug 20, 2024

ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiota

Mingyang Cheng, Bin Xu, Yu Sun…·Xin Cao

This study shows ASB3 worsens inflammatory bowel disease by destabilizing TRAF6 and altering gut microbiota, suggesting ASB3 inhibition could be a therapeutic strategy.

16 citations

mouseproteomics

𝕏 PostBluesky